An exploration into how flawed incentives and contractual loopholes between manufacturers and pharmacy benefit managers ...

As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how ...

In the first part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, defines the term, and explains how ...

In the third part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, comments on how mobile and ...

The acquisition of Cryoport’s specialty courier business is now finalized, with a value of approximately $200 million.

How practical is this form of pricing in the pharma setting? The ink was barely dry on President Trump’s drug pricing-related executive order when it was reported 1 that the Trump Administration ...

In the final part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, illustrates how data-driven ...

In the second part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, describes why this technology is essential for pharmaceutical safety and efficacy.

In order to succeed in today’s outcomes-driven healthcare landscape, pharmaceutical companies must move from traditional ...

A recent Pharmaceutical Executive article highlights how antibody-drug conjugates are experiencing a renaissance in oncology, with innovations in targeting, linker technology, and payload design ...